Oncogenesis, malignant melanoma

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The development of tumours is much more complex than initially assumed. Multiple point mutations, translocations, amplifications and deletions in genes probably contribute to the development of a tumour (see mutation below). There are also numerous epigenetic (see below epigenetics) changes.

ClassificationThis section has been translated automatically.

  • MAP kinase signalling pathway: This pathway refers to a series of multi-step signal transduction pathways that are involved in the regulation of embryogenesis, cell differentiation, cell growth and programmed cell death, among other things.
  • The high rate of mutations underlines their key role in the development of malignant melanoma. Chemically, these are protein kinases (molar mass 36-44 kDa), which phosphorylate other proteins at specific serine/threonine residues (serine/threonine kinases).

Authors

Last updated on: 29.10.2020